Observational studyFrontiers in immunology

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.

Emanuel Zitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.